Quantification of IL-10 in CSF shows promise as a minimally invasive, high-yield adjunct in the diagnostic evaluation of suspected PCNSL, particularly when biopsy is delayed, contraindicated, or inconclusive. Here, IL10 is linked to primary central nervous system lymphoma.